Stocks and Investing Stocks and Investing
Tue, January 24, 2023

Joshua Schimmer Maintained (TGTX) at Buy with Increased Target to $25 on, Jan 24th, 2023


Published on 2024-10-28 01:04:01 - WOPRAI, Joshua Schimmer
  Print publication without navigation


Joshua Schimmer of Evercore ISI Group, Maintained "TG Therapeutics, Inc." (TGTX) at Buy with Increased Target from $16 to $25 on, Jan 24th, 2023.

Joshua has made no other calls on TGTX in the last 4 months.



There are 4 other peers that have a rating on TGTX. Out of the 4 peers that are also analyzing TGTX, 0 agree with Joshua's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Joshua


  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $6 on, Friday, December 30th, 2022
  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $23 on, Friday, December 30th, 2022
  • Alec Stranahan of "B of A Securities" Maintained at Sell with Increased Target to $6 on, Thursday, December 29th, 2022
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Thursday, December 29th, 2022

Contributing Sources